PETRONI, GIULIA

PETRONI, GIULIA  

Medicina Sperimentale e Clinica  

Mostra records
Risultati 1 - 20 di 48 (tempo di esecuzione: 0.024 secondi).
Titolo Data di pubblicazione Autore(i) File
A novel allergen-adjuvant conjugate suitable for specific immunotherapy of respiratory allergy 2013 Lucia Filì;Alessandra Vultaggio;Elisa Cardilicchia;Cinzia Manuelli;Andrea Casini;Francesca Nencini;Laura Maggi;Sara Pratesi;Giulia Petroni;Francesca Boscaro;Antonio Guarna;Ernesto G. Occhiato;Sergio Romagnani;Enrico Maggi;Paola Parronchi
A novel nDer p2-conjugated TLR7 down-modulates Th2-associated lung inflammation by using a therapeutical protocol 2013 Pratesi S ; Nencini F; Petroni G;Cardilicchia E; Fili L; Casini A; Guarna A; Romagnani S; Parronchi P; Maggi E; Vultaggio A
Allergological in vitro and in vivo evaluation of patients with hypersensitivity reactions to infliximab. 2013 Matucci A; Pratesi S; Petroni G; Nencini F; Virgili G; Milla M; Maggi E; Vultaggio A.
Anticancer effects against colorectal cancer models of chloro(triethylphosphine)gold(I) encapsulated in PLGA–PEG nanoparticles 2021 Menconi A.; Marzo T.; Massai L.; Pratesi A.; Severi M.; Petroni G.; Antonuzzo L.; Messori L.; Pillozzi S.; Cirri D.
Apoptotic caspases inhibit abscopal responses to radiation and identify a new prognostic biomarker for breast cancer patients 2019 Rodriguez-Ruiz, Maria Esperanza; Buqué, Aitziber; Hensler, Michal; Chen, Jonathan; Bloy, Norma; Petroni, Giulia; Sato, Ai; Yamazaki, Takahiro; Fucikova, Jitka; Galluzzi, Lorenzo
Assays and strategies for immunogenicity assessment of biological agents. 2014 Nencini F; Pratesi S; Petroni G; Matucci A; Maggi E; Vultaggio A.
Autophagy in major human diseases 2021 Klionsky, Daniel J; Petroni, Giulia; Amaravadi, Ravi K; Baehrecke, Eric H; Ballabio, Andrea; Boya, Patricia; Bravo-San Pedro, José Manuel; Cadwell, Ken; Cecconi, Francesco; Choi, Augustine M K; Choi, Mary E; Chu, Charleen T; Codogno, Patrice; Colombo, Maria Isabel; Cuervo, Ana Maria; Deretic, Vojo; Dikic, Ivan; Elazar, Zvulun; Eskelinen, Eeva-Liisa; Fimia, Gian Maria; Gewirtz, David A; Green, Douglas R; Hansen, Malene; Jäättelä, Marja; Johansen, Terje; Juhász, Gábor; Karantza, Vassiliki; Kraft, Claudine; Kroemer, Guido; Ktistakis, Nicholas T; Kumar, Sharad; Lopez-Otin, Carlos; Macleod, Kay F; Madeo, Frank; Martinez, Jennifer; Meléndez, Alicia; Mizushima, Noboru; Münz, Christian; Penninger, Josef M; Perera, Rushika M; Piacentini, Mauro; Reggiori, Fulvio; Rubinsztein, David C; Ryan, Kevin M; Sadoshima, Junichi; Santambrogio, Laura; Scorrano, Luca; Simon, Hans-Uwe; Simon, Anna Katharina; Simonsen, Anne; Stolz, Alexandra; Tavernarakis, Nektarios; Tooze, Sharon A; Yoshimori, Tamotsu; Yuan, Junying; Yue, Zhenyu; Zhong, Qing; Galluzzi, Lorenzo; Pietrocola, Federico
Cancer Immunotherapy with CDK7 Inhibitors 2020 Petroni, Giulia; Galluzzi, Lorenzo
Caspase 2 and p53 Reunited in Tumor Control 2020 Petroni, Giulia; Vitale, Ilio; Galluzzi, Lorenzo
Cellular senescence in the response of HR+ breast cancer to radiotherapy and CDK4/6 inhibitors 2023 Vanessa Klapp, Aitziber Buqué, Norma Bloy, Ai Sato, Takahiro Yamazaki, Xi Kathy Zhou, Silvia C. Formenti, Lorenzo Galluzzi, Giulia Petroni
Challenges in the treatment of small cell lung cancer in the era of immunotherapy and molecular classification 2023 Caliman, Enrico; Fancelli, Sara; Petroni, Giulia; Gatta Michelet, Marta Rita; Cosso, Federica; Ottanelli, Carlotta; Mazzoni, Francesca; Voltolini, Luca; Pillozzi, Serena; Antonuzzo, Lorenzo
Chlorido and bromido oxaliplatin analogues as potential agents for CRC treatment: Solution behavior, protein binding and cytotoxicity evaluation 2018 Marzo, Tiziano; Pratesi, Alessandro; Cirri, Damiano; Pillozzi, Serena; Petroni, Giulia; Guerri, Annalisa; Arcangeli, Annarosa; Messori, Luigi; Gabbiani, Chiara
Circulating T cells to infliximab are detectable mainly in treated patients developing anti-drug antibodies and hypersensitivity reactions 2016 Vultaggio A.; Petroni G.; Pratesi S.; Nencini F.; Cammelli D.; Milla M.; Prignano F.; Annese V.; Romagnani S.; Maggi E.; Matucci A.
Clarithromycin inhibits autophagy in colorectal cancer by regulating the hERG1 potassium channel interaction with PI3K 2020 Petroni, Giulia; Bagni, Giacomo; Iorio, Jessica; Duranti, Claudia; Lottini, Tiziano; Stefanini, Matteo; Kragol, Goran; Becchetti, Andrea; Arcangeli, Annarosa
Cytofluorometric assessment of cell cycle progression in irradiated cells 2022 Jiménez-Cortegana, Carlos; Klapp, Vanessa; Bloy, Norma; Galassi, Claudia; Sato, Ai; Yamazaki, Takahiro; Buqué, Aitziber; Galluzzi, Lorenzo; Petroni, Giulia
Data describing the effects of the Macrolide Antibiotic Clarithromycin on preclinical mouse models of Colorectal Cancer 2019 Petroni G.; Stefanini M.; Pillozzi S.; Crociani O.; Becchetti A.; Arcangeli A.
Drug-Specific Th2 Cells and IgE Antibodies in a Patient with Anaphylaxis to Rituximab 2012 Alessandra Vultaggio;Andrea Matucci;Francesca Nencini;Sara Pratesi;Giulia Petroni;Daniele Cammelli;Renato Alterini;Luigi Rigacci;Sergio Romagnani;Enrico Maggi
hERG1 and HIF-2α Behave as Biomarkers of Positive Response to Bevacizumab in Metastatic Colorectal Cancer Patients 2020 Iorio, Jessica; Lastraioli, Elena; Tofani, Lorenzo; Petroni, Giulia; Antonuzzo, Lorenzo; Messerini, Luca; Perrone, Giuseppe; Caputo, Damiano; Francesconi, Maria; Amato, Maria Michelina; Cadei, Moris; Arcangeli, Giuseppina; Villanacci, Vincenzo; Boni, Luca; Coppola, Roberto; Di Costanzo, Francesco; Arcangeli, Annarosa
HERG1 positivity and Glut-1 negativity identifies high-risk TNM stage I and II colorectal cancer patients, regardless of adjuvant chemotherapy 2016 Muratori, Leonardo; Petroni, Giulia; Antonuzzo, Lorenzo; Boni, Luca; Iorio, Jessica; Lastraioli, Elena; Bartoli, Gianluca; Messerini, Luca; Di Costanzo, Francesco; Arcangeli, Annarosa
Immunofluorescence microscopy-based assessment of cytosolic DNA accumulation in mammalian cells 2021 Sato, Ai; Buque, Aitziber; Yamazaki, Takahiro; Bloy, Norma; Petroni, Giulia; Galluzzi, Lorenzo